Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The applicability of the central line-associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients.

Autor: van den Bosch CH; Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands., Frakking FNJ; Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands., Loeffen YGT; Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, Utrecht, The Netherlands., van Tinteren H; Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MHWA; Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands., van de Wetering MD; Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands., van der Bruggen JT; Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Publikováno v: European journal of haematology [Eur J Haematol] 2024 May; Vol. 112 (5), pp. 832-839. Date of Electronic Publication: 2024 Jan 31.

The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.

Autor: van den Bosch CH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: C.H.vandenBosch-4@prinsesmaximacentrum.nl., Jeremiasse B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Bruggen JT; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., Frakking FNJ; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands., Loeffen YGT; Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, Utrecht, the Netherlands., van de Ven CP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Fiocco MF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Mathematical Institute, Leiden, the Netherlands; Leiden University Medical Center, Leiden, the Netherlands., van de Wetering MD; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Publikováno v: The Journal of hospital infection [J Hosp Infect] 2022 May; Vol. 123, pp. 143-155. Date of Electronic Publication: 2021 Nov 09.

Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.

Autor: van den Bosch CH; Department of Pediatric Surgical Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: cedervandenbosch@gmail.com., van der Bruggen JT; Department of Medical Microbiology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. Electronic address: j.t.vanderbruggen@umcutrecht.nl., Frakking FNJ; Department of Medical Microbiology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, The Netherlands. Electronic address: f.n.j.frakking@umcutrecht.nl., Terwisscha van Scheltinga CEJ; Department of Pediatric Surgical Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: C.E.J.TerwisschavanScheltinga@prinsesmaximacentrum.nl., van de Ven CP; Department of Pediatric Surgical Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: c.p.vandeven-4@umcutrecht.nl., van Grotel M; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: M.vanGrotel@prinsesmaximacentrum.nl., Wellens LM; Department of Pediatric Surgical Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: l.m.wellens@prinsesmaximacentrum.nl., Loeffen YGT; Department of Pediatric Infectious diseases and Immunology, Wilhelmina Children's Hospital, Lundlaan 6, 3584, EA, Utrecht, The Netherlands. Electronic address: Y.G.T.Loeffen-2@umcutrecht.nl., Fiocco M; Medical Statistics, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands; Mathematical Institute, Niels Bohrweg 1, 2333, CA, Leiden, the Netherlands; Leiden University, Rapenburg 70, 2311, EZ, Leiden, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, 2333, ZC, Leiden, The Netherlands. Electronic address: m.fiocco@lumc.nl., Wijnen MHWA; Department of Pediatric Surgical Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. Electronic address: M.H.W.Wijnen-5@prinsesmaximacentrum.nl.

Publikováno v: Journal of pediatric surgery [J Pediatr Surg] 2019 Sep; Vol. 54 (9), pp. 1894-1900. Date of Electronic Publication: 2018 Oct 30.